| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1987Sci...237.1210G |
| P356 | DOI | 10.1126/SCIENCE.3306918 |
| P698 | PubMed publication ID | 3306918 |
| P50 | author | Georges E Grau | Q42712823 |
| P2093 | author name string | Lambert PH | |
| Piguet PF | |||
| Vassalli P | |||
| Fajardo LF | |||
| Allet B | |||
| P433 | issue | 4819 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| cerebral malaria | Q2822915 | ||
| P304 | page(s) | 1210-1212 | |
| P577 | publication date | 1987-09-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria | |
| P478 | volume | 237 |
| Q34183889 | A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines |
| Q35468420 | A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice |
| Q37222297 | A central role for free heme in the pathogenesis of severe malaria: the missing link? |
| Q42470353 | A cytochemical study of cerebrovascular lesions in mice infected with Plasmodium berghei |
| Q34001680 | A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice |
| Q35813897 | A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes |
| Q43772123 | A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria |
| Q37962343 | A proinflammatory mediator with potential relevance in aging |
| Q30479825 | A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria |
| Q34297619 | A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults |
| Q40640004 | A study of the anti-pyretic effect of quinine, an alkaloid effective against cerebral malaria, on fever induced by bacterial endotoxin and yeast in rats |
| Q41076771 | Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro |
| Q44385519 | Activation of nuclear transcription factor-kappa B is associated with the induction of inhibitory kappa B kinase-beta and involves differential activation of protein kinase C and protein tyrosine kinases during fatal murine cerebral malaria |
| Q39063480 | Activation of the host response in human plasmodium falciparum malaria: Relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels |
| Q27473449 | Active immunization by a dengue virus-induced cytokine |
| Q37015150 | Age-related CD4(+)CD25(+)Foxp3(+) regulatory T-cell responses during Plasmodium berghei ANKA infection in mice susceptible or resistant to cerebral malaria |
| Q33586454 | Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans |
| Q64970354 | Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. |
| Q33436577 | Alpha/beta interferon in serum from children with the hemolytic uremic syndrome |
| Q48019357 | Amelioration of murine cerebral malaria by dietary restriction |
| Q34170436 | An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria |
| Q36353675 | An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis |
| Q37890197 | Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset |
| Q34706971 | Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection |
| Q36089514 | Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice |
| Q34116823 | Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria |
| Q36936433 | Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells |
| Q38760299 | Body temperature changes during inflammation: their mediation and nutritional significance |
| Q27300897 | Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria |
| Q36952534 | Bovine helper T cell clones recognize five distinct epitopes on Babesia bovis merozoite antigens |
| Q47887974 | Breakdown of the blood-brain barrier in murine cerebral malaria |
| Q36019905 | CD36 modulates proinflammatory cytokine responses to Plasmodium falciparum glycosylphosphatidylinositols and merozoites by dendritic cells |
| Q37377899 | CD40 and the immune response to parasitic infections |
| Q47920069 | CaM kinase II-alpha activity, levels and Ca/calmodulin dependent phosphorylation of substrate proteins in mice brain during fatal murine cerebral malaria |
| Q39527191 | Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses |
| Q39516473 | Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells. |
| Q67903116 | Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-γ, interleukin 3 and interleukin 6 release after triggering of the CD33/T cell receptor activation pathway |
| Q38284130 | Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria |
| Q99418046 | Caspase-8 mediates inflammation and disease in rodent malaria |
| Q36966617 | Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites |
| Q35443895 | Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice |
| Q34192908 | Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? |
| Q34007519 | Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection |
| Q37427832 | Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi |
| Q34109370 | Cerebral malaria and immunogenetics |
| Q37983138 | Cerebral malaria pathogenesis: revisiting parasite and host contributions. |
| Q41307980 | Cerebral malaria pathogenesis: what can we learn from microarray analysis? |
| Q34574447 | Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis |
| Q37661151 | Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease |
| Q41917909 | Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells |
| Q46942379 | Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria |
| Q33760891 | Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria |
| Q33810622 | Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein |
| Q30482595 | Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities |
| Q48807462 | Comparative, behavioural and electrocortical effects of tumor necrosis factor-alpha and interleukin-1 microinjected into the locus coeruleus of rat. |
| Q36761460 | Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. |
| Q45269337 | Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria |
| Q54185769 | Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. |
| Q37032980 | Constitutive synthesis of tumor necrosis factor in the thymus |
| Q77741621 | Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-alpha |
| Q35782432 | Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria |
| Q35179749 | Correlation of hemorrhage, axonal damage, and blood-tissue barrier disruption in brain and retina of Malawian children with fatal cerebral malaria |
| Q35441422 | Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria |
| Q48037129 | Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria |
| Q37264802 | Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro. |
| Q47886203 | Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria |
| Q71874965 | Cytokine and immunoglobulin subclass responses of rats to infection withEimeria nieschulzi |
| Q43961790 | Cytokine expression in the brains of Toxocara canis-infected mice |
| Q35559322 | Cytokine profile suggesting that murine cerebral malaria is an encephalitis |
| Q42446198 | Cytokine-regulatory activity and therapeutic efficacy of cinnamyl derivatives in endotoxin shock |
| Q37049274 | Cytokines and anti-disease immunity to malaria |
| Q36215895 | Cytokines and retroviruses |
| Q47889076 | Cytokines, integrins and the pathogenesis of malaria |
| Q35216393 | Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria |
| Q36366324 | Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease |
| Q36318958 | DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients. |
| Q33332861 | Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice |
| Q28587942 | Deletion of T cells bearing the V beta8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria |
| Q39324279 | Differential Induction of TGF-β Regulates Proinflammatory Cytokine Production and Determines the Outcome of Lethal and NonlethalPlasmodium yoeliiInfections |
| Q55384045 | Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria. |
| Q36360977 | Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains |
| Q48848104 | Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells |
| Q67539013 | Distinct in vivo functions of two macrophage subpopulations as evidenced by studies using macrophage-deficient op/op mouse |
| Q33426367 | Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria |
| Q42155741 | Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria |
| Q35830630 | Dual role of tumor necrosis factor-alpha in angiogenesis |
| Q42144187 | Duality and complexity of allergic type inflammatory mechanisms in determining the outcome of malaria disease |
| Q38689845 | Dynamic interactions of Plasmodium spp. with vascular endothelium |
| Q35102256 | Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression |
| Q38852851 | Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria. |
| Q48036040 | Early activation of microglia in the pathogenesis of fatal murine cerebral malaria |
| Q36951979 | Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice |
| Q35831698 | Early microvascular changes in murine cerebral malaria detected in retinal wholemounts |
| Q39476819 | Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. |
| Q47872620 | Effects of endotoxin and dexamethasone on cerebral malaria in mice |
| Q48743413 | Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers |
| Q33802804 | Electron microscopic features of brain edema in rodent cerebral malaria in relation to glial fibrillary acidic protein expression |
| Q38850431 | Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria |
| Q39129403 | Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria |
| Q26996354 | Endogenous mouse mammary tumor viruses (mtv): new roles for an old virus in cancer, infection, and immunity |
| Q36999646 | Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection |
| Q36967376 | Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression |
| Q37764571 | Evaluation of TNF as antiviral, antibacterial and antiparasitic agent |
| Q37178878 | Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria |
| Q35054703 | Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. |
| Q26772866 | Expanding the antimalarial toolkit: Targeting host-parasite interactions |
| Q27315279 | Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream |
| Q36100829 | Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. |
| Q47976889 | Experimental asexual blood stage malaria immunity |
| Q40617817 | Experimental cerebral malaria: possible new mechanisms in the TNF-induced microvascular pathology. |
| Q60044955 | Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunate |
| Q35907413 | Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection. |
| Q48037587 | Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria |
| Q35833094 | Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. |
| Q43240481 | Falciparum malaria and hypoglycaemia |
| Q35977092 | Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studies |
| Q37548166 | Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria |
| Q35882362 | Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. |
| Q67699659 | Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance |
| Q36368277 | Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis |
| Q41935223 | Glycosylphosphatidylinositols of Plasmodium chabaudi chabaudi: a basis for the study of malarial glycolipid toxins in a rodent model |
| Q47900405 | Haptoglobin and malaria |
| Q34627646 | Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. |
| Q35850162 | High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection |
| Q48019620 | High levels of circulating IL-10 in human malaria |
| Q38182192 | Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? |
| Q21032480 | How malaria has affected the human genome and what human genetics can teach us about malaria |
| Q41752336 | Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum |
| Q47870933 | Human cerebral malaria: characterization of malarial antibodies in cerebrospinal fluid |
| Q41601330 | Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering |
| Q43985079 | Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction |
| Q40160423 | Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection |
| Q74449418 | Humanization of a mouse neutralizing monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha) |
| Q40767060 | Hyperkinetic shock and cerebral malaria |
| Q36086895 | IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain |
| Q27317276 | IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection |
| Q37359865 | Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9. |
| Q37742018 | Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies |
| Q47854962 | Immunization against cerebral pathology in Plasmodium berghei-infected mice |
| Q47850408 | Immunization with heat-killed Toxoplasma gondii stimulates an early IFN-gamma response and induces protection against virulent murine malaria |
| Q38241650 | Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells |
| Q43662589 | Immunological aspects of cerebral lesions in murine malaria |
| Q38627927 | Immunology of human malaria. A cellular perspective |
| Q72600523 | Immunology of leishmaniasis |
| Q37929759 | Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria |
| Q57584257 | Immunopathology and Dexamethasone Therapy in a New Model for Malaria-associated Acute Respiratory Distress Syndrome |
| Q33600266 | Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature |
| Q33446020 | Immunopathology of thrombocytopenia in experimental malaria. |
| Q39514773 | Immunoregulation of malarial infection: balancing the vices and virtues |
| Q35750152 | Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria |
| Q41214653 | In vivo pharmacological effects of ciclosporin and some analogues |
| Q34540765 | Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. |
| Q48015339 | Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. |
| Q36306918 | Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production |
| Q39171649 | Induction of experimental cerebral malaria is independent of TLR2/4/9. |
| Q33931700 | Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1 |
| Q33825536 | Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome |
| Q54378442 | Inflammation and anti-tumor resistance. IV. Induction of cytostatic activity of murine peritoneal cells by a mouse granuloma protein |
| Q42751873 | Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice |
| Q34539758 | Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models |
| Q28742640 | Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria |
| Q28742222 | Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations |
| Q38260972 | Innate sensing of malaria parasites |
| Q37162665 | Interactions of CD4+ and CD8+ human T lymphocytes from malaria-unprimed donors with Plasmodium falciparum schizont stage |
| Q38001532 | Interferon signatures in immune disorders and disease |
| Q41939276 | Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine |
| Q39413194 | Interferon-gamma is essential for the development of cerebral malaria |
| Q36437643 | Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. |
| Q36353843 | Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia |
| Q36831191 | Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. |
| Q47823424 | Interleukin-10 modulates susceptibility in experimental cerebral malaria. |
| Q35175642 | Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis |
| Q41348046 | Is TNF really involved in cachexia? |
| Q64098482 | KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria |
| Q47862501 | Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria |
| Q47862495 | Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model |
| Q34685370 | Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain |
| Q38994034 | Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria |
| Q37186185 | Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria |
| Q40834422 | Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress |
| Q48440751 | Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines |
| Q48023307 | Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. |
| Q57954052 | Malaria diagnosis: memorandum from a WHO meeting |
| Q47885958 | Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. |
| Q35831427 | Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum |
| Q47848282 | Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease |
| Q34999453 | Malaria pathogenesis: a jigsaw with an increasing number of pieces |
| Q45195504 | Malaria tropica with activation of blood coagulation and detection of tumor necrosis factor (NF-alpha) in serum |
| Q38295245 | Malaria, Epstein-Barr virus, and the genesis of lymphomas |
| Q37488090 | Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. |
| Q47898297 | Malaria. Binding of infected red cells |
| Q37881983 | Malaria: modification of the red blood cell and consequences in the human host |
| Q40483034 | Malaria: toxins, cytokines and disease. |
| Q47911455 | Malarial parasites induce TNF production by macrophages |
| Q40511940 | Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia |
| Q36362408 | Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. |
| Q47910677 | Mitochondrial anomalies are associated with the induction of intrinsic cell death proteins-Bcl(2), Bax, cytochrome-c and p53 in mice brain during experimental fatal murine cerebral malaria |
| Q48676035 | Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I. |
| Q39629285 | Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases |
| Q67700016 | Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo application |
| Q34292144 | Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor |
| Q90202158 | Monocyte-derived dendritic cells in malaria |
| Q42816910 | Monokine production by microglial cell clones |
| Q33375007 | Murine cerebral malaria development is independent of toll-like receptor signaling |
| Q36513451 | Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice |
| Q34194659 | Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific |
| Q33818748 | Natural regulatory T cells in malaria: host or parasite allies? |
| Q39552619 | Nephropathy in falciparum malaria |
| Q35223903 | Neurological manifestations of malaria |
| Q48012328 | Neuropathological studies on Plasmodium yoelii nigeriensis-induced malaria in mice |
| Q47863152 | Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria |
| Q34833840 | Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology |
| Q53808732 | Nutrition and cytokine action. |
| Q41916459 | Oral artesunate prevents Plasmodium berghei Anka infection in mice |
| Q48859553 | Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production |
| Q34851496 | P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature |
| Q33617104 | Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines |
| Q67545055 | Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats |
| Q30661769 | Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans |
| Q35838590 | Pathogenesis of malaria and clinically similar conditions |
| Q35094647 | Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment |
| Q35801788 | Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies |
| Q47848359 | Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice |
| Q48029680 | Patterns of haemozoin accumulation in tissue |
| Q72463082 | Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells |
| Q35806583 | Plant Hormone Salicylic Acid Produced by a Malaria Parasite Controls Host Immunity and Cerebral Malaria Outcome |
| Q73156672 | Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-azar). Association with activity of the disease and clinical remission following antimonial therapy |
| Q35822120 | Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis |
| Q37643899 | Plasmodium berghei sporozoites acquire virulence and immunogenicity during mosquito hemocoel transit |
| Q39063466 | Plasmodium falciparum Malaria: reduction of endothelial cell apoptosis in vitro |
| Q40269475 | Plasmodium falciparum varies in its ability to induce tumor necrosis factor. |
| Q35764021 | Platelets play an important role in TNF-induced microvascular endothelial cell pathology |
| Q34301265 | Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum |
| Q61671887 | Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-α by human macrophages |
| Q36230993 | Polymorphisms in the tumor necrosis factor alpha (TNF-alpha) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-alpha mRNA in infected brain tissue |
| Q37544546 | Potential efficacy of citicoline as adjunct therapy in treatment of cerebral malaria |
| Q36356489 | Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection |
| Q36355438 | Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation |
| Q70176974 | Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies |
| Q36988519 | Prevention of murine cerebral malaria by a stable prostacyclin analog |
| Q41816416 | Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence |
| Q40267674 | Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline, and tumor necrosis factor secretion is reduced |
| Q78207112 | Production of nitric oxide in mouse peritoneal macrophages after priming with interferon-gamma by the stem of Sinomenium acutum |
| Q54380601 | Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. |
| Q33632812 | Protein glycosylation in the malaria parasite |
| Q48747362 | Protein tyrosine kinase inhibitors decrease lipopolysaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures |
| Q39449735 | Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid |
| Q35178181 | Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria. |
| Q35809747 | Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier |
| Q27324676 | Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis |
| Q47953551 | Reduced activity of the epithelial sodium channel in malaria-induced pulmonary oedema in mice. |
| Q33975360 | Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. |
| Q47925580 | Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex |
| Q40340968 | Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes |
| Q41020476 | Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia |
| Q39656512 | Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria |
| Q35765275 | Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response |
| Q48036126 | Respective role of TNF receptors in the development of experimental cerebral malaria. |
| Q33338408 | Role of CD40-CVD40L in mouse severe malaria |
| Q33331078 | Role of ICAM-1 (CD54) in the development of murine cerebral malaria |
| Q67275918 | Role of TNF and IL-1 in infections with Toxoplasma gondii |
| Q35775790 | Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. |
| Q38761419 | Roles of tumour necrosis factor in the illness and pathology of malaria |
| Q39446904 | Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria |
| Q40938056 | S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha |
| Q47869317 | Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice |
| Q24681600 | Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states |
| Q33377266 | Severe falciparum malaria (21 cases) |
| Q29614923 | Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster |
| Q36361193 | Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites |
| Q47892787 | Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo |
| Q90573372 | Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections |
| Q44083043 | Splenocyte apoptosis in Plasmodium berghei ANKA infection: possible role of TNF-α and TGF-β. |
| Q36310946 | Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. |
| Q35397626 | Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria |
| Q34727467 | Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum |
| Q35811348 | Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis |
| Q46893767 | Susceptibility of tumour necrosis factor-alpha genetically deficient mice to Trypanosoma congolense infection |
| Q47910654 | Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria |
| Q41070474 | Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice |
| Q35758478 | Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. |
| Q36710017 | Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria |
| Q47852393 | T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria. |
| Q79777744 | T cell-derived TNF down-regulates acute airway response to endotoxin |
| Q40617270 | T cells and malaria: is Th1 cell activation a prerequisite for pathology? |
| Q40617264 | T cells and malarial pathology |
| Q47872716 | T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects |
| Q37929568 | T lymphocyte-derived colony-stimulating factors |
| Q33749632 | TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria |
| Q67677221 | TNF in Pathophysiology: Biosynthetic Regulation |
| Q40799707 | TNF-alpha and insulin-dependent diabetes mellitus |
| Q43925144 | TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype |
| Q37643882 | Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria |
| Q35728956 | The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology |
| Q35912396 | The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis. |
| Q64105078 | The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity |
| Q39160358 | The application of anti-Toso antibody enhances CD8(+) T cell responses in experimental malaria vaccination and disease |
| Q58765358 | The biological basis and clinical symptoms of CAR-T therapy-associated toxicites |
| Q39204110 | The common mediator of shock, cachexia, and tumor necrosis. |
| Q35137538 | The contribution of natural killer complex loci to the development of experimental cerebral malaria |
| Q47848772 | The importance of T cell homing and the spleen in reaching a balance between malaria immunity and immunopathology: the moulding of immunity by early exposure to cross-reactive organisms |
| Q36663126 | The involvement of TNF, IL-1 and IL-6 in the immune response to protozoan parasites |
| Q42250672 | The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. |
| Q35187770 | The pathophysiology of falciparum malaria |
| Q38211414 | The potential role of interferons and interferon antagonists in inflammatory disease |
| Q40617260 | The response of gamma delta T cells in malaria infections: a hypothesis. |
| Q45942909 | The role of channel formation in the mechanism of action of tumor necrosis factors. |
| Q37655274 | The role of chemokines in severe malaria: more than meets the eye. |
| Q38004234 | The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. |
| Q40724094 | The roles of cytokines produced in the immune response to the erythrocytic stages of mouse malarias |
| Q45902248 | The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM). |
| Q39781830 | The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes |
| Q35820994 | The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia |
| Q33422123 | Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines |
| Q35837250 | Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study |
| Q77647317 | Topically applied pentoxifylline has no effect on allergic patch responses |
| Q22306157 | Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? |
| Q33752033 | Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice |
| Q30411019 | Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria |
| Q36232642 | Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts |
| Q48002147 | Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections |
| Q35777068 | Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis. |
| Q35095995 | Tumor necrosis factor alpha and the anemia associated with murine malaria. |
| Q40374180 | Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties |
| Q33592023 | Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection |
| Q40040068 | Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. |
| Q36687011 | Tumor necrosis factor and immunopathology |
| Q39859633 | Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans. |
| Q40153660 | Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum |
| Q41178310 | Tumor necrosis factor in human disease |
| Q36229956 | Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions |
| Q36357123 | Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis |
| Q36976057 | Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum |
| Q35764305 | Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. |
| Q58064740 | Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway |
| Q36357597 | Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease |
| Q36356708 | Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis |
| Q42737018 | Tumour necrosis factor |
| Q68774951 | Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis |
| Q40644530 | Tumour necrosis factor and associated cytokines in the host's response to malaria |
| Q40771591 | Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture |
| Q60692946 | Tumour necrosis factor α (TNF) in neuroimmunology |
| Q48021783 | Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria |
| Q37916679 | Tumour necrosis factor: a cytokine with multiple biological activities |
| Q48539496 | Tungsten treatment prevents tumor necrosis factor-induced injury of brain endothelial cells |
| Q35103990 | Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages |
| Q36504376 | VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria |
| Q48009520 | Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria |
| Q36504381 | Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria |
| Q41746479 | WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability |
| Q36636738 | Where Are We in the Quest for Vaccines for Malaria? |
| Q47965600 | c-Jun N terminal kinases (JNK) are activated in the brain during the pathology of experimental cerebral malaria |
Search more.